Derivatives after the crash March 18, 2015 X LinkedIn Email Show more sharing options Copy Link URLCopied! Print X LinkedIn Email Rosali Pretorius and Tom Harkus of Dentons consider the key objectives of Emir and their impact on the buy-side’s use of OTC derivatives Unlock this content. The content you are trying to view is exclusive to our subscribers. To unlock this content: Take a Free Trial or Login